Point72 Asset Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.69M Hold
19,800
﹤0.01% 2433
2025
Q4
$1.56M Buy
19,800
+14,000
+241% +$1.1M ﹤0.01% 2620
2025
Q3
$464K Hold
5,800
﹤0.01% 1948
2025
Q2
$527K Buy
5,800
+4,800
+480% +$438K ﹤0.01% 1767
2025
Q1
$93.7K Sell
1,000
-3,400
-77% -$304K ﹤0.01% 1923
2024
Q4
$400K Sell
4,400
-15,400
-78% -$1.47M ﹤0.01% 1718
2024
Q3
$2.06M Buy
+19,800
New +$2.02M 0.01% 1186
2023
Q1
Sell
-12,800
Closed -$1.01M 2268
2022
Q4
$1.01M Buy
12,800
+9,200
+256% +$690K ﹤0.01% 1047
2022
Q3
$253K Hold
3,600
﹤0.01% 1249
2022
Q2
$289K Buy
+3,600
New +$281K ﹤0.01% 1247

Other funds holding CL

Point72 Asset Management's CL Position: Q1 2026 in Review

Point72 Asset Management sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 234,869 shares — an estimated $20.9M sold.

Point72 Asset Management first reported a position in CL in Q1 2016 and held it in 17 quarters. The position peaked at $113M in Q4 2022. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Point72 Asset Management reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
  • Point72 Asset Management sold 234,869 Colgate-Palmolive shares in Q1 2026, an estimated $20.9M.
  • Point72 Asset Management first reported a position in Colgate-Palmolive in Q1 2016 and held it in 17 quarters.
  • Point72 Asset Management's Colgate-Palmolive position peaked at $113M in Q4 2022.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.